Delivery Order SPE2DB22D3016-SPE2DB24FAVX4
Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,004.95, is a delivery order for the drug CAPLYTA 10.5 MG CAPSULE 30S. It has an ultimate completion date of April 7, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract, valued at $1,023.73, is a firm fixed-price delivery order that has an ultimate completion date of July 29, 2024. As one of the largest pharmaceutical distributors in the U.S., Amerisourcebergen has been awarded numerous federal contracts to provide a wide range...
- This federal contract award is a delivery order with a firm fixed price of $1,069.34 awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CAPLYTA 21 MG CAPSULE 30S, with a period of performance through May 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp is a Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) valued at $4,358.07. The award covers the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through June 25, 2024. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides medical products and supplies to federal government agencies, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,728.54 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product CAPLYTA 21 MG CAPSULE 30S. This award is not associated with a set-aside program. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a single-award Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $5,628.27 delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $5,794.03. This non-competitive delivery order is structured as a firm fixed-price contract with an ultimate completion date of August 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) with a contract ceiling value of $7,558.14. The order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,018.07 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CAPLYTA 21 MG CAPSULE 30S, with a completion date of March 7, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,392.43, is for the delivery of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...